Literature DB >> 17364377

Factor structure of patient and caregiver ratings on the dementia quality of life instrument.

Rebecca E Ready1, Brian R Ott, Janet Grace.   

Abstract

Preliminary evidence suggests that quality of life reports from patients diagnosed with mild cognitive impairment (MCI) and mild Alzheimer's disease (AD) are as reliable and valid as data provided by caregivers. To date, no studies compared the factor structure of data provided by caregivers and patients. Factor analyses are important to conduct because they are an indicator of validity. This study compared the factor structure of patient and caregiver reports on the Dementia Quality of Life scale (DQoL). Participants (N=67) were patients diagnosed with amnestic MCI or mild AD and their caregivers. Principal axis factor analyses were run separately on patient and caregiver report data. The three-factor solutions for patient and caregiver data were nearly identical. Three factors corresponding to positive affect, negative affect, and aesthetics emerged reliably from analyses. Thus, data from patients demonstrated a factor structure that was highly consistent with caregiver report data and conformed to meaningful psychological constructs.

Entities:  

Mesh:

Year:  2007        PMID: 17364377     DOI: 10.1080/138255891007056

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  2 in total

1.  Validation of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-being (FACIT-Sp12) on French Old People.

Authors:  Océane Agli; Nathalie Bailly; Claude Ferrand
Journal:  J Relig Health       Date:  2017-04

2.  WHEDA study: effectiveness of occupational therapy at home for older people with dementia and their caregivers--the design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres.

Authors:  Sebastian Voigt-Radloff; Maud Graff; Rainer Leonhart; Katrin Schornstein; Myrra Vernooij-Dassen; Marcel Olde-Rikkert; Michael Huell
Journal:  BMC Geriatr       Date:  2009-10-02       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.